Beta Bionics (BBNX) Insider Trading & Ownership $19.09 -0.40 (-2.05%) As of 06/13/2025 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Beta Bionics (NASDAQ:BBNX) Insider Buying and Selling ActivityNumber OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$17.57MNumber OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$80.84K Get BBNX Insider Trade Alerts Want to know when executives and insiders are buying or selling Beta Bionics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BBNX Insider Buying and Selling by Quarter Beta Bionics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/2/2025Mark HopmanInsiderSell868$17.89$15,528.52 6/2/2025Mike MensingerInsiderSell1,115$17.89$19,947.35 6/2/2025Stephen FeiderCFOSell1,497$17.89$26,781.33 6/2/2025Steven Jon RussellInsiderSell1,039$17.89$18,587.71 1/31/2025Hadley Harbor Aggre WellingtonMajor ShareholderBuy1,000,000$17.00$17,000,000.00 1/31/2025Mike MensingerInsiderBuy33,350$17.00$566,950.00 (Data available from 1/1/2013 forward) BBNX Insider Trading Activity - Frequently Asked Questions Who is on Beta Bionics's Insider Roster? The list of insiders at Beta Bionics includes Hadley Harbor Aggre Wellington, Mark Hopman, Mike Mensinger, Stephen Feider, and Steven Jon Russell. Learn more on insiders at BBNX. Which Beta Bionics insiders have been buying company stock? The following insiders have purchased BBNX shares in the last 24 months: Hadley Harbor Aggre Wellington ($17,000,000.00), and Mike Mensinger ($566,950.00). How much insider buying is happening at Beta Bionics? Insiders have purchased a total of 1,033,350 BBNX shares in the last 24 months for a total of $17,566,950.00 bought. Which Beta Bionics insiders have been selling company stock? The following insiders have sold BBNX shares in the last 24 months: Mark Hopman ($15,528.52), Mike Mensinger ($19,947.35), Stephen Feider ($26,781.33), and Steven Jon Russell ($18,587.71). How much insider selling is happening at Beta Bionics? Insiders have sold a total of 4,519 Beta Bionics shares in the last 24 months for a total of $80,844.91 sold. More Insider Trading Tools from MarketBeat Related Companies NVST Insider Ownership LIVN Insider Ownership WRBY Insider Ownership LMAT Insider Ownership NVCR Insider Ownership ENOV Insider Ownership CNMD Insider Ownership EYE Insider Ownership LQDA Insider Ownership CDRE Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Summer Stocks With Insider Buying and Analyst Support3 Tightly-Held Growth Stocks Set Up for Short SqueezesTankers, Takedowns & Air Taxis: Insiders Are Buying These 3 Names3 Tech Stocks Insiders Are Buying: Speculative Plays for JuneDividend Investors Looking for an Edge? 3 Stocks Insiders Bought This page (NASDAQ:BBNX) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredGet in stocks now - and get out on this dateGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beta Bionics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Beta Bionics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
